Evidence map›Paper›PMID 19223652›Full record

ArticleAmerican journal of physiology. Endocrinology and metabolism2009

Insulin blunts the response of glucose-excited neurons in the ventrolateral-ventromedial hypothalamic nucleus to decreased glucose.

Victoria E Cotero, Vanessa H Routh

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in American journal of physiology. Endocrinology and metabolism, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 70 citations in OpenAlex.

  1. Brain Nutrient Sensing: A Unifying Framework.Annual review of physiology · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Victoria E CoteroDepartment of Pharmacology and Physiology, New Jersey Medical School, Newark, NJ 07101-1709, USA.
Vanessa H Routh
Rutgers, The State University of New Jersey · US

Funding

THE ARCUATE K ATP CHANNEL IN HEALTH, OBESITY AND DIABETER01DK055619 · NIDDK · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI ROUTH, VANESSA H · 2000 to 2008
$2.2M
NIDDK NIH HHS 2-R01-DK-55619NIDDK NIH HHS R01 DK055619NINDS NIH HHS 5F31NS05681
6 · The paper itself

Abstract

Insulin signaling is dysfunctional in obesity and diabetes. Moreover, central glucose-sensing mechanisms are impaired in these diseases. This is associated with abnormalities in hypothalamic glucose-sensing neurons. Glucose-sensing neurons reside in key areas of the brain involved in glucose and energy homeostasis, such as the ventromedial hypothalamus (VMH). Our results indicate that insulin opens the K(ATP) channel on VMH GE neurons in 5, 2.5, and 0.1 mM glucose. Furthermore, insulin reduced the sensitivity of VMH GE neurons to a decrease in extracellular glucose level from 2.5 to 0.1 mM. This change in the glucose sensitivity in the presence of insulin was reversed by the phosphatidylinositol 3-kinase (PI3K) inhibitor wortmannin (10 nM) but not by the mitogen-activated kinase (MAPK) inhibitor PD-98059 (PD; 50 microM). Finally, neither the AMPK inhibitor compound C nor the AMPK activator AICAR altered the activity of VMH GE neurons. These data suggest that insulin attenuates the ability of VMH GE neurons to sense decreased glucose via the PI3K signaling pathway. Furthermore, these data are consistent with the role of insulin as a satiety factor. That is, in the presence of insulin, glucose levels must decline further before GE neurons respond. Thus, the set point for detection of glucose deficit and initiation of compensatory mechanisms would be lowered.

Indexed as

Aminoimidazole CarboxamideAndrostadienesAnimalsFlavonoidsGlucoseInsulinIn Vitro TechniquesMaleMicroscopy, InterferenceNeuronsPatch-Clamp TechniquesPhosphatidylinositol 3-KinasesPotassium Channels, Inwardly RectifyingProtein Kinase InhibitorsPyrazolesPyrimidines2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-oneAICA ribonucleotideAminoimidazole CarboxamideAndrostadienesdorsomorphinFlavonoidsGlucoseInsulinPhosphatidylinositol 3-KinasesPotassium Channels, Inwardly RectifyingProtein Kinase InhibitorsPyrazolesPyrimidinesRibonucleotidesWortmannin

Identifiers

PMID19223652
PMCPMC2681311
OpenAlexW2171944673

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.